CMV-Infektionen beim Früh- und Reifgeborenen

• Literatur

• 1 Robert Koch-Institut. Epidemiologisches Bulletin Nr. 3; RKI-Ratgeber für Ärzte. Zytomegalievirus-Infektion. 20. Januar 2014. Im Internet: http://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2014/Ausgaben/03_14.pdf?__blob=publicationFile ; Zugriff am 08.02.2015
• 2 Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005; 5: 70
• 3 Stern H, Tucker SM. Cytomegalovirus infection in the newborn and in early childhood. Three atypical cases. Lancet 1965; 2: 1268-1271
• 4 Townsend CL, Cortina-Borja M, Peckham CS et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS 2008; 22: 973-981
• 5 Wang C, Zhang X, Bialek S et al. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2011; 52: e11-e13
• 6 Manicklal S, Emery VC, Lazzarotto T et al. The „silent“ global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26: 86-102
• 7 Enders G, Daiminger A, Lindemann L et al. Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Med Microbiol Immunol 2012; 201: 303-309
• 8 AWMF. Labordiagnostik schwangerschaftsrelevanter Virusinfektionen, S2k-Leitlinie. AWMF Registernummer 0093/001. 2014
• 9 Johnson J, Anderson B, Pass F. Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol 2012; 55: 521-530
• 10 Hamprecht K, Bissinger AL, Arellano-Galindo J et al. Intrafamilial transmission of human cytomegalovirus (HCMV): long-term dynamics of epitope-specific antibody response in context of avidity maturation. J Clin Virol 2014; 60: 119-126
• 11 Vauloup-Fellous C, Picone O, Cordier AG et al. Does hygiene counselling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3 year prospective study in a French hospital. J Clin Virol 2009; 46: 49-53
• 12 Schuster V, Bührer C, Hamprecht K et al. Zytomegalovirus-Infektionen. In: Deutsche Gesellschaft für pädiatrische Infektiologie e.V., Hrsg. Handbuch Infektionen bei Kindern und Jugendlichen. 7. Aufl. Stuttgart: Thieme; 2013
• 13 Statistisches Bundesamt. Geburten. Im Internet: https://www.destatis.de/DE/ZahlenFakten/GesellschaftStaat/Bevoelkerung/_Doorpage/Geburten_Suche.html ; Zugriff am 15.02.2015
• 14 Gilsdorf A. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2013. Berlin: Robert Koch-Institut; 2014
• 15 Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17: 253-276
• 16 Kimberlin DW, Lin CY, Sánchez PJ et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143: 16-25
• 17 Ross SA, Boppana SB. Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis 2004; 16: 44-49
• 18 Kimberlin DW, Jester PM, Sánchez PJ et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015; 372: 933-943
• 19 Engman ML, Lewensohn-Fuchs I, Mosskin M et al. Congenital cytomegalovirus infection: the impact of cerebral cortical malformations. Acta Paediatr 2010; 99: 1344-1349
• 20 Townsend CL, Peckham CS, Tookey PA. Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed 2011; 96: 398-403
• 21 Gandhi RS, Fernandez-Alvarez JR, Rabe H. Management of congenital cytomegalovirus infection: an evidence-based approach. Acta Paediatr 2010; 99: 509-515
• 22 Kadambari S, Williams EJ, Luck S et al. Evidence based management guidelines for the detection and treatment of congenital CMV. Early Hum Dev 2011; 87: 723-728
• 23 Boppana SB, Ross SA, Novak Z et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 2010; 303: 1375-1382
• 24 Boppana SB, Ross SA, Shimamura M et al. National Institute on Deafness and Other Communication Disorders CHIMES Study. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011; 364: 2111-2118
• 25 Koyano S, Inoue N, Nagamori T et al. Newborn screening of congenital cytomegalovirus infection using saliva can be influenced by breast feeding. Arch Dis Child Fetal Neonatal Ed 2013; 98: F182
• 26 Halwachs-Baumann G, Genser B, Pailer S et al. Human cytomegalovirus load in various body fluids of congenitally infected newborns. J Clin Virol 2002; 25: 81-87
• 27 Oliver SE, Cloud GA, Sánchez PJ et al. National Institute of Allergy, Infectious Diseases Collaborative Antiviral Study Group. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 2009; 46: 22-26
• 28 Kimberlin DW, Acosta EP, Sánchez PJ et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 2008; 197: 836-845
• 29 Hamprecht K, Maschmann J, Vochem M et al. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001; 357: 513-518
• 30 Snydman DR, Werner BG, Meissner HC et al. Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates. Pediatr Infect Dis J 1995; 14: 34-40
• 31 Josephson CD, Caliendo AM, Easley KA et al. Blood transfusion and breast milk transmission of cytomegalovirus in very low-birth-weight infants: a prospective cohort study. JAMA Pediatr 2014; 168: 1054-1062
• 32 Buxmann H, Miljak A, Fischer D et al. Incidence and clinical outcome of cytomegalovirus transmission via breast milk in preterm infants </= 31 weeks. Acta Paediatr 2009; 98: 270-276
• 33 Meier J, Lienicke U, Tschirch E et al. Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants. J Clin Microbiol 2005; 43: 1318-1324
• 34 Bryant P, Morley C, Garland S et al. Cytomegalovirus transmission from breast milk in premature babies: does it matter?. Arch Dis Child Fetal Neonatal Ed 2002; 87: 75-77
• 35 Dworsky M, Yow M, Stagno S et al. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 1983; 72: 295-299
• 36 Mosca F, Pugni L, Barbi M et al. Transmission of cytomegalovirus. Lancet 2001; 357: 1800
• 37 Hamele M, Flanagan R, Loomis CA et al. Severe morbidity and mortality with breast milk associated cytomegalovirus infection. Pediatr Infect Dis J 2010; 29: 84-86
• 38 Cheong JL, Cowan FM, Modi N. Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period. Arch Dis Child Fetal Neonatal Ed 2004; 89: 367-369
• 39 Mehler K, Oberthuer A, Lang-Roth R et al. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22–24 weeks’ gestation after transmission via breast milk. Neonatology 2014; 105: 27-32
• 40 Knorr B, Kessler U, Pöschl J et al. A haemophagocytic lymphohistiocytosis(HLH)-like picture following breastmilk transmitted cytomegalovirus infection in a preterm infant. Scand J Infect Dis 2007; 39: 173-176
• 41 Ballard RA, Drew WL, Hufnagle KG et al. Acquired cytomegalovirus infection in preterm infants. Am J Dis Child 1979; 133: 482-485
• 42 Neuberger P, Hamprecht K, Vochem M et al. Case-control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants. J Pediatr 2006; 148: 326-331
• 43 Kurath S, Halwachs-Baumann G, Müller W et al. Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review. Clin Microbiol Infect 2010; 16: 1172-1178
• 44 Vochem M, Hamprecht K, Jahn G et al. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 1998; 17: 53-58
• 45 Doctor S, Friedman S, Dunn MS et al. Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr 2005; 94: 53-58
• 46 Buxmann H, Wittekindt B, Fischer D et al. Use of Cytomegalovirus-hyperimmunoglobuline (CMV-HIG) in extreme low birth weight infants (ELBWI) with symptomatic CMV-infections: A consecutive serie of four cases. ABSTRACT BOOK, Combined meetings: 4th Congenital CMV Conference and 14th International CMV/BetaHerpesvirus Workshop October 29^th to November 2^nd . San Francisco: 2012
• 47 Kumar ML, Nankervis GA, Jacobs IB et al. Congenital and postnatally acquired cytomegalovirus infections: long-term follow-up. J Pediatr 1984; 104: 674-679
• 48 Granström M, Leinikki P, Santavuori P et al. Perinatal cytomegalovirus infection in man. Arch Dis Child 1977; 52: 354-359
• 49 Paryani SG, Yeager AS, Hosford-Dunn H et al. Sequelae of acquired cytomegalovirus infection in premature and sick term infants. J Pediatr 1985; 107: 451-456
• 50 Bevot A, Hamprecht K, Krägeloh-Mann I et al. Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk. Acta Paediatr 2012; 101: e167-e172
• 51 Goelz R, Meisner C, Bevot A et al. Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk. Arch Dis Child Fetal Neonatal Ed 2013; 98: 430-433
• 52 Brecht KF, Goelz R, Bevot A et al. Postnatal Human Cytomegalovirus Infection in Preterm Infants Has Long Term Neuropsychological Sequelae. J Pediatr 2014; pii: 0022-3476 , DOI:
• 53 Johnston M, Landers S, Noble L et al. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129: e827-e841
• 54 Agence Française de Sécurité Sanitaire des Aliments. Recommandations d’hygiène pour la preparation et la conservation des biberons. 2005 Im Internet: https://www.anses.fr/sites/default/files/documents/MIC-Ra-BIB.pdf ; Zugriff am 22.03.2015
• 55 Ernährungskommission der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde. Prävention von CMV-Infektionen bei Frühgeborenen durch Muttermilch. Update 2008 – Empfehlung. Monatsschr Kinderheilkd 2009; 157: 795-797
• 56 Hamprecht K, Maschmann J, Müller D et al. Cytomegalovirus (CMV) inactivation in breast milk: reassessment of pasteurization and freeze-thawing. Pediatr Res 2004; 56: 529-535
• 57 Goelz R, Hihn E, Hamprecht K et al. Effects of different CMV-heat-inactivation-methods on growth factors in human breast milk. Pediatr Res 2009; 65: 458-461
• 58 Bapistella S, Hamprecht K, Thomas W et al. Wirksamkeit und Machbarkeit der CMV-Inaktivierung durch Kurzzeitpasteurisierung von Muttermilch auf neonatologischen Intensivstationen. Abstrakt 40. GNPI Jahrestagung. Stuttgart/Tübingen: 2015
• 59 Evans TJ, Ryley HC, Neale LM et al. Effect of storage and heat on antimicrobial proteins in human milk. Arch Dis Child 1978; 53: 239-241
• 60 Ford JE, Law BA, Marshall VM et al. Influence of the heat treatment of human milk on some of its protective constituents. J Pediatr 1977; 90: 29-35
• 61 Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990; 336: 1519-1523
• 62 Hylander MA, Strobino DM, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics 1998; 102: E38
• 63 Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999; 103: 1150-1157
• 64 Hylander MA, Strobino DM, Pezzullo JC et al. Association of human milk feedings with a reduction in retinopathy of prematurity among very low birthweight infants. J Perinatol 2001; 21: 356-362
• 65 Vohr BR, Poindexter BB, Dusick AM et al. NICHD Neonatal Research Network. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics 2006; 118: e115-e123
• 66 Buxmann H, Falk M, Goelz R et al. Feeding of very low birth weight infants born to HCMV-seropositive mothers in Germany, Austria and Switzerland. Acta Paediatr 2010; 99: 1819-1823